Skip to main content

Want a detailed portfolio tracker?

GCTS-WS
NYSE
$0.35

GCT Semiconductor Holding Inc Wt Exp (GCTS-WS)

GCT Therapeutics (GCTS-WS) is a forward-thinking biotechnology company dedicated to advancing gene therapy and precision medicine to address significant unmet medical needs in healthcare. With a robust development pipeline and a diverse intellectual property portfolio, the company is leveraging strategic collaborations to enhance its innovative capabilities and market position. Backed by a seasoned management team, GCT Therapeutics is poised to deliver transformative solutions that promise improved patient outcomes, positioning it as a compelling investment opportunity within the dynamic biotechnology landscape.

Market Cap

$30M

Beta (5Y)

-0.49

Price Chart

Valuation
Market Cap$30M
Profitability
Total Revenue (TTM)$4.29M
EBITDA-$34M
EPS-$0.78
Financial Health
Debt-to-Equity-78.1%
Growth & Risk
Beta (5Y)-0.49
Sharpe Ratio1.57